Researchers at McGill University have uncovered a surprising twist in how dopamine affects movement, overturning a ...

For decades, Parkinson’s disease has been framed as a straightforward story about dying brain cells and dwindling dopamine. A ...

A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...

Oral bacteria that migrate to the gut can generate metabolites that reach the brain and accelerate Parkinson’s disease.

Hope is preparing for close-out meetings with the FDA. Chang said the team is “hopeful to advance to a phase 3 confirmatory trial” of the stem cell therapy candidate.

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...

Tammy Corrigan was just 50 years old when she was diagnosed with Parkinson’s disease. In May 2022, Corrigan met with Guillaume Lamotte, MD, MSc, a neurologist and assistant professor in the Department ...

Parkinson’s disease affects over 10 million people globally, with incidence increasing after age 60. Dopamine-producing neuron loss leads to both motor and non-motor symptoms, including tremors, sleep ...